Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction

OBJECTIVES: Autologous CD133+ bone marrow stem cells may improve cardiac function. This randomized, single‐blind clinical trial inquired whether a combined transepicardial and transseptal implantation of CD133+ stem cells during coronary artery bypass grafting (CABG) improve cardiac function with ej...

Descripción completa

Detalles Bibliográficos
Autores principales: Soetisna, Tri Wisesa, Sukmawan, Renan, Setianto, Budhi, Mansyur, Muchtaruddin, Murni, Tri Wahyu, Listiyaningsih, Erlin, Santoso, Anwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187333/
https://www.ncbi.nlm.nih.gov/pubmed/32048356
http://dx.doi.org/10.1111/jocs.14454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187333/
https://www.ncbi.nlm.nih.gov/pubmed/32048356
http://dx.doi.org/10.1111/jocs.14454

Ejemplares similares